$AMGN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMGEN INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AMGEN INC. Get notifications about new insider transactions in AMGEN INC for free.
Page: < prev 1 ... 3 4 5 6 7 8 9 10 11 ... 27 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 29 2014 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Payment of Exercise | F | 111.41 | 783 | 87,234 | 187,860 | 188.6 K to 187.9 K (-0.42 %) |
Apr 29 2014 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Payment of Exercise | F | 111.41 | 1,566 | 174,468 | 188,643 | 190.2 K to 188.6 K (-0.82 %) |
Apr 29 2014 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Payment of Exercise | F | 113.72 | 3,617 | 411,325 | 190,209 | 193.8 K to 190.2 K (-1.87 %) |
Apr 29 2014 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Grant | A | 0.00 | 1,795 | 0 | 7,017 | 5.2 K to 7 K (+34.37 %) |
Apr 29 2014 | AMGN | AMGEN INC | PELHAM JUDITH C | Director | Grant | A | 0.00 | 1,795 | 0 | 15,734 | 13.9 K to 15.7 K (+12.88 %) |
Apr 29 2014 | AMGN | AMGEN INC | OMENN GILBERT S | Director | Grant | A | 0.00 | 1,795 | 0 | 180,547 | 178.8 K to 180.5 K (+1.00 %) |
Apr 29 2014 | AMGN | AMGEN INC | Jacks Tyler | Director | Grant | A | 0.00 | 1,795 | 0 | 3,685 | 1.9 K to 3.7 K (+94.97 %) |
Apr 29 2014 | AMGN | AMGEN INC | HERRINGER FRANK C | Director | Grant | A | 0.00 | 1,795 | 0 | 20,230 | 18.4 K to 20.2 K (+9.74 %) |
Apr 29 2014 | AMGN | AMGEN INC | HENDERSON REBECCA M | Director | Grant | A | 0.00 | 1,795 | 0 | 7,372 | 5.6 K to 7.4 K (+32.19 %) |
Apr 29 2014 | AMGN | AMGEN INC | de Carbonnel Francois | Director | Payment of Exercise | F | 113.72 | 539 | 61,295 | 19,590 | 20.1 K to 19.6 K (-2.68 %) |
Apr 29 2014 | AMGN | AMGEN INC | de Carbonnel Francois | Director | Grant | A | 0.00 | 1,795 | 0 | 20,148 | 18.4 K to 20.1 K (+9.78 %) |
Apr 29 2014 | AMGN | AMGEN INC | Garland Greg C. | Director | Grant | A | 0.00 | 1,795 | 0 | 2,224 | 429 to 2.2 K (+418.41 %) |
Apr 29 2014 | AMGN | AMGEN INC | ECKERT ROBERT | Director | Grant | A | 0.00 | 1,795 | 0 | 3,674 | 1.9 K to 3.7 K (+95.53 %) |
Apr 29 2014 | AMGN | AMGEN INC | COFFMAN VANCE D | Director | Grant | A | 0.00 | 1,795 | 0 | 21,580 | 19.8 K to 21.6 K (+9.07 %) |
Apr 29 2014 | AMGN | AMGEN INC | BIONDI FRANK | Director | Grant | A | 0.00 | 1,795 | 0 | 31,814 | 30 K to 31.8 K (+5.98 %) |
Apr 29 2014 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Grant | A | 0.00 | 1,795 | 0 | 31,159 | 29.4 K to 31.2 K (+6.11 %) |
Mar 18 2014 | AMGN | AMGEN INC | SCOTT DAVID J | SVP, Gen. Counsel & ... | Payment of Exercise | F | 123.96 | 14,278 | 1,769,901 | 92,213 | 106.5 K to 92.2 K (-13.41 %) |
Mar 18 2014 | AMGN | AMGEN INC | Tross Stuart A | SVP, Human Resource ... | Payment of Exercise | F | 123.96 | 1,647 | 204,162 | 30,734 | 32.4 K to 30.7 K (-5.09 %) |
Mar 18 2014 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Payment of Exercise | F | 123.96 | 1,377 | 170,693 | 18,611 | 20 K to 18.6 K (-6.89 %) |
Mar 18 2014 | AMGN | AMGEN INC | Michael A Kelly | Acting CFO | Payment of Exercise | F | 123.96 | 1,377 | 170,693 | 42,914 | 44.3 K to 42.9 K (-3.11 %) |
Mar 18 2014 | AMGN | AMGEN INC | MCNAMEE BRIAN M | EVP | Payment of Exercise | F | 123.96 | 9,411 | 1,166,588 | 79,810 | 89.2 K to 79.8 K (-10.55 %) |
Mar 18 2014 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 123.96 | 7,683 | 952,385 | 76,588 | 84.3 K to 76.6 K (-9.12 %) |
Mar 18 2014 | AMGN | AMGEN INC | Dittrich Thomas J.W. | VP, Finance & CAO | Payment of Exercise | F | 123.96 | 2,316 | 287,091 | 18,655 | 21 K to 18.7 K (-11.04 %) |
Mar 18 2014 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Payment of Exercise | F | 123.96 | 26,891 | 3,333,408 | 193,826 | 220.7 K to 193.8 K (-12.18 %) |
Mar 18 2014 | AMGN | AMGEN INC | Balachandran Madhavan | EVP, Operations | Gift | G | 0.00 | 5,280 | 0 | 40,131 | 34.9 K to 40.1 K (+15.15 %) |
Mar 18 2014 | AMGN | AMGEN INC | Balachandran Madhavan | EVP, Operations | Gift | G | 0.00 | 5,280 | 0 | 46,363 | 51.6 K to 46.4 K (-10.22 %) |
Mar 18 2014 | AMGN | AMGEN INC | Balachandran Madhavan | EVP, Operations | Payment of Exercise | F | 123.96 | 5,763 | 714,381 | 51,623 | 57.4 K to 51.6 K (-10.04 %) |
Mar 14 2014 | AMGN | AMGEN INC | HOOPER ANTHONY C | EVP, Global Commerc ... | Payment of Exercise | F | 124.27 | 27,540 | 3,422,396 | 116,210 | 143.8 K to 116.2 K (-19.16 %) |
Mar 07 2014 | AMGN | AMGEN INC | Tross Stuart A | SVP, Human Resource ... | Grant | A | 0.00 | 4,381 | 0 | 32,273 | 27.9 K to 32.3 K (+15.71 %) |
Mar 07 2014 | AMGN | AMGEN INC | SCOTT DAVID J | SVP, Gen. Counsel & ... | Grant | A | 0.00 | 27,362 | 0 | 106,415 | 79.1 K to 106.4 K (+34.61 %) |
Mar 07 2014 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Grant | A | 0.00 | 3,663 | 0 | 19,938 | 16.3 K to 19.9 K (+22.51 %) |
Mar 07 2014 | AMGN | AMGEN INC | MCNAMEE BRIAN M | EVP | Grant | A | 0.00 | 18,405 | 0 | 89,096 | 70.7 K to 89.1 K (+26.04 %) |
Mar 07 2014 | AMGN | AMGEN INC | Dittrich Thomas J.W. | VP, Finance & CAO | Grant | A | 0.00 | 4,207 | 0 | 20,971 | 16.8 K to 21 K (+25.10 %) |
Mar 07 2014 | AMGN | AMGEN INC | Michael A Kelly | Acting CFO | Grant | A | 0.00 | 3,663 | 0 | 44,239 | 40.6 K to 44.2 K (+9.03 %) |
Mar 07 2014 | AMGN | AMGEN INC | HOOPER ANTHONY C | EVP, Global Commerc ... | Grant | A | 0.00 | 52,777 | 0 | 143,642 | 90.9 K to 143.6 K (+58.08 %) |
Mar 07 2014 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Grant | A | 0.00 | 51,534 | 0 | 220,439 | 168.9 K to 220.4 K (+30.51 %) |
Mar 07 2014 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Grant | A | 0.00 | 14,724 | 0 | 84,163 | 69.4 K to 84.2 K (+21.20 %) |
Mar 07 2014 | AMGN | AMGEN INC | Balachandran Madhavan | EVP, Operations | Grant | A | 0.00 | 11,043 | 0 | 57,195 | 46.2 K to 57.2 K (+23.93 %) |
Mar 07 2014 | AMGN | AMGEN INC | de Carbonnel Francois | Director | Option Exercise | M | 50.44 | 5,000 | 252,200 | 0 | |
Mar 07 2014 | AMGN | AMGEN INC | de Carbonnel Francois | Director | Option Exercise | M | 58.43 | 5,000 | 292,150 | 0 | |
Mar 07 2014 | AMGN | AMGEN INC | de Carbonnel Francois | Director | Sell | S | 126.69 | 1,000 | 126,690 | 18,343 | 19.3 K to 18.3 K (-5.17 %) |
Mar 07 2014 | AMGN | AMGEN INC | de Carbonnel Francois | Director | Payment of Exercise | F | 126.19 | 6,021 | 759,790 | 19,343 | 25.4 K to 19.3 K (-23.74 %) |
Mar 07 2014 | AMGN | AMGEN INC | de Carbonnel Francois | Director | Buy | M | 50.44 | 5,000 | 252,200 | 25,364 | 20.4 K to 25.4 K (+24.55 %) |
Mar 07 2014 | AMGN | AMGEN INC | de Carbonnel Francois | Director | Buy | M | 58.43 | 5,000 | 292,150 | 20,364 | 15.4 K to 20.4 K (+32.54 %) |
Mar 04 2014 | AMGN | AMGEN INC | HOOPER ANTHONY C | EVP, Global Commerc ... | Payment of Exercise | F | 124.02 | 7,537 | 934,739 | 90,865 | 98.4 K to 90.9 K (-7.66 %) |
Feb 26 2014 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Option Exercise | M | 62.55 | 5,000 | 312,750 | 0 | |
Feb 26 2014 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Payment of Exercise | F | 124.36 | 2,515 | 312,765 | 29,364 | 31.9 K to 29.4 K (-7.89 %) |
Feb 26 2014 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Buy | M | 62.55 | 5,000 | 312,750 | 31,879 | 26.9 K to 31.9 K (+18.60 %) |
Feb 14 2014 | AMGN | AMGEN INC | HENDERSON REBECCA M | Director | Option Exercise | M | 58.43 | 3,000 | 175,290 | 0 | |
Feb 14 2014 | AMGN | AMGEN INC | HENDERSON REBECCA M | Director | Option Exercise | M | 63.11 | 17,000 | 1,072,870 | 3,000 | |
Feb 14 2014 | AMGN | AMGEN INC | HENDERSON REBECCA M | Director | Sell | S | 123.53 | 20,000 | 2,470,680 | 5,549 | 25.5 K to 5.5 K (-78.28 %) |
Feb 14 2014 | AMGN | AMGEN INC | HENDERSON REBECCA M | Director | Buy | M | 58.43 | 3,000 | 175,290 | 25,549 | 22.5 K to 25.5 K (+13.30 %) |
Feb 14 2014 | AMGN | AMGEN INC | HENDERSON REBECCA M | Director | Buy | M | 63.11 | 17,000 | 1,072,870 | 22,549 | 5.5 K to 22.5 K (+306.36 %) |
Feb 26 2014 | AMGN | AMGEN INC | HERRINGER FRANK C | Director | Option Exercise | M | 62.55 | 5,000 | 312,750 | 0 | |
Feb 26 2014 | AMGN | AMGEN INC | HERRINGER FRANK C | Director | Gift | G | 0.00 | 2,513 | 0 | 6,152 | 3.6 K to 6.2 K (+69.06 %) |
Feb 26 2014 | AMGN | AMGEN INC | HERRINGER FRANK C | Director | Gift | G | 0.00 | 2,513 | 0 | 18,362 | 20.9 K to 18.4 K (-12.04 %) |
Feb 26 2014 | AMGN | AMGEN INC | HERRINGER FRANK C | Director | Payment of Exercise | F | 125.79 | 2,487 | 312,840 | 20,875 | 23.4 K to 20.9 K (-10.65 %) |
Feb 26 2014 | AMGN | AMGEN INC | HERRINGER FRANK C | Director | Buy | M | 62.55 | 5,000 | 312,750 | 23,362 | 18.4 K to 23.4 K (+27.23 %) |
Feb 14 2014 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Option Exercise | M | 62.55 | 6,392 | 399,820 | 0 | |
Feb 14 2014 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Option Exercise | M | 62.55 | 58,608 | 3,665,930 | 0 | |
Feb 14 2014 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Payment of Exercise | F | 121.24 | 47,135 | 5,714,647 | 168,905 | 216 K to 168.9 K (-21.82 %) |
Feb 14 2014 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Buy | M | 62.55 | 6,392 | 399,820 | 216,040 | 209.6 K to 216 K (+3.05 %) |
Feb 14 2014 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Buy | M | 62.55 | 58,608 | 3,665,930 | 209,648 | 151 K to 209.6 K (+38.80 %) |
Feb 04 2014 | AMGN | AMGEN INC | Tross Stuart A | SVP, Human Resource ... | Grant | A | 0.00 | 1,681 | 0 | 27,892 | 26.2 K to 27.9 K (+6.41 %) |
Feb 04 2014 | AMGN | AMGEN INC | SCOTT DAVID J | SVP, Gen. Counsel & ... | Grant | A | 0.00 | 3,362 | 0 | 79,053 | 75.7 K to 79.1 K (+4.44 %) |
Feb 04 2014 | AMGN | AMGEN INC | MCNAMEE BRIAN M | EVP | Grant | A | 0.00 | 4,707 | 0 | 70,691 | 66 K to 70.7 K (+7.13 %) |
Feb 04 2014 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Grant | A | 0.00 | 1,092 | 0 | 16,275 | 15.2 K to 16.3 K (+7.19 %) |
Feb 04 2014 | AMGN | AMGEN INC | Michael A Kelly | Acting CFO | Grant | A | 0.00 | 8,406 | 0 | 40,576 | 32.2 K to 40.6 K (+26.13 %) |
Feb 04 2014 | AMGN | AMGEN INC | HOOPER ANTHONY C | EVP, Global Commerc ... | Grant | A | 0.00 | 5,044 | 0 | 98,402 | 93.4 K to 98.4 K (+5.40 %) |
Feb 04 2014 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Grant | A | 0.00 | 5,044 | 0 | 69,439 | 64.4 K to 69.4 K (+7.83 %) |
Feb 04 2014 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Grant | A | 0.00 | 15,132 | 0 | 151,040 | 135.9 K to 151 K (+11.13 %) |
Feb 04 2014 | AMGN | AMGEN INC | Balachandran Madhavan | EVP, Operations | Grant | A | 0.00 | 4,707 | 0 | 46,152 | 41.4 K to 46.2 K (+11.36 %) |
Dec 18 2013 | AMGN | AMGEN INC | AMGEN INC | 10% Owner | Option Exercise | X | 6.40 | 13,355 | 85,501 | 0 | |
Dec 18 2013 | AMGN | AMGEN INC | AMGEN INC | 10% Owner | Option Exercise | C | 0.00 | 117,361 | 0 | 0 | |
Dec 18 2013 | AMGN | AMGEN INC | AMGEN INC | 10% Owner | Option Exercise | C | 0.00 | 108,932 | 0 | 0 | |
Dec 18 2013 | AMGN | AMGEN INC | AMGEN INC | 10% Owner | Buy | P | 7.00 | 272,142 | 1,904,994 | 541,399 | 269.3 K to 541.4 K (+101.07 %) |
Dec 18 2013 | AMGN | AMGEN INC | AMGEN INC | 10% Owner | Buy | X | 6.40 | 1,141 | 7,305 | 269,257 | 268.1 K to 269.3 K (+0.43 %) |
Dec 18 2013 | AMGN | AMGEN INC | AMGEN INC | 10% Owner | Buy | C | 0.00 | 268,116 | 0 | 268,116 | 0 to 268.1 K |
Dec 18 2013 | AMGN | AMGEN INC | AMGEN INC | 10% Owner | Buy | C | 0.00 | 448,767 | 0 | 448,767 | 0 to 448.8 K |
Oct 29 2013 | AMGN | AMGEN INC | Peacock Jonathan M | EVP & CFO | Payment of Exercise | F | 116.32 | 13,045 | 1,517,394 | 94,414 | 107.5 K to 94.4 K (-12.14 %) |
Oct 29 2013 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Payment of Exercise | F | 116.32 | 376 | 43,736 | 15,146 | 15.5 K to 15.1 K (-2.42 %) |
Oct 29 2013 | AMGN | AMGEN INC | MCNAMEE BRIAN M | EVP | Grant | A | 0.00 | 11,176 | 0 | 65,900 | 54.7 K to 65.9 K (+20.42 %) |
Oct 29 2013 | AMGN | AMGEN INC | Tross Stuart A | SVP, Human Resource ... | Grant | A | 0.00 | 3,180 | 0 | 26,128 | 22.9 K to 26.1 K (+13.86 %) |
Oct 29 2013 | AMGN | AMGEN INC | Garland Greg C. | Director | Grant | A | 0.00 | 429 | 0 | 429 | 0 to 429 |
Sep 05 2013 | AMGN | AMGEN INC | Balachandran Madhavan | EVP, Operations | Option Exercise | M | 58.43 | 18,000 | 1,051,740 | 6,000 | |
Sep 05 2013 | AMGN | AMGEN INC | Balachandran Madhavan | EVP, Operations | Sell | S | 112.77 | 18,000 | 2,029,768 | 34,851 | 52.9 K to 34.9 K (-34.06 %) |
Sep 05 2013 | AMGN | AMGEN INC | Balachandran Madhavan | EVP, Operations | Gift | G | 0.00 | 18,000 | 0 | 41,133 | 59.1 K to 41.1 K (-30.44 %) |
Sep 05 2013 | AMGN | AMGEN INC | Balachandran Madhavan | EVP, Operations | Gift | G | 0.00 | 18,000 | 0 | 52,851 | 34.9 K to 52.9 K (+51.65 %) |
Sep 05 2013 | AMGN | AMGEN INC | Balachandran Madhavan | EVP, Operations | Buy | M | 58.43 | 18,000 | 1,051,740 | 59,133 | 41.1 K to 59.1 K (+43.76 %) |
Aug 30 2013 | AMGN | AMGEN INC | PELHAM JUDITH C | Director | Gift | G | 0.00 | 9,210 | 0 | 13,939 | 23.1 K to 13.9 K (-39.79 %) |
Aug 30 2013 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Gift | G | 0.00 | 910 | 0 | 26,879 | 27.8 K to 26.9 K (-3.27 %) |
Aug 30 2013 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Sell | S | 109.66 | 4,582 | 502,462 | 27,789 | 32.4 K to 27.8 K (-14.15 %) |
Jun 05 2013 | AMGN | AMGEN INC | Amgen Ventures LLC | 10% Owner | Option Exercise | C | 0.00 | 952,381 | 0 | 0 | |
Jun 05 2013 | AMGN | AMGEN INC | Amgen Ventures LLC | 10% Owner | Buy | P | 15.00 | 16,666 | 249,990 | 334,126 | 317.5 K to 334.1 K (+5.25 %) |
Jun 05 2013 | AMGN | AMGEN INC | Amgen Ventures LLC | 10% Owner | Buy | C | 0.00 | 317,460 | 0 | 317,460 | 0 to 317.5 K |
May 24 2013 | AMGN | AMGEN INC | Dittrich Thomas J.W. | VP, Finance & CAO | Option Exercise | M | 54.69 | 1,980 | 108,286 | 4,020 | |
May 24 2013 | AMGN | AMGEN INC | Dittrich Thomas J.W. | VP, Finance & CAO | Option Exercise | M | 58.43 | 2,150 | 125,625 | 2,150 | |
May 24 2013 | AMGN | AMGEN INC | Dittrich Thomas J.W. | VP, Finance & CAO | Option Exercise | M | 50.44 | 2,000 | 100,880 | 0 | |
May 24 2013 | AMGN | AMGEN INC | Dittrich Thomas J.W. | VP, Finance & CAO | Sell | S | 104.78 | 6,130 | 642,296 | 16,733 | 22.9 K to 16.7 K (-26.81 %) |
May 24 2013 | AMGN | AMGEN INC | Dittrich Thomas J.W. | VP, Finance & CAO | Buy | M | 54.69 | 1,980 | 108,286 | 22,863 | 20.9 K to 22.9 K (+9.48 %) |
May 24 2013 | AMGN | AMGEN INC | Dittrich Thomas J.W. | VP, Finance & CAO | Buy | M | 58.43 | 2,150 | 125,625 | 20,883 | 18.7 K to 20.9 K (+11.48 %) |
May 24 2013 | AMGN | AMGEN INC | Dittrich Thomas J.W. | VP, Finance & CAO | Buy | M | 50.44 | 2,000 | 100,880 | 18,733 | 16.7 K to 18.7 K (+11.95 %) |
May 21 2013 | AMGN | AMGEN INC | Balachandran Madhavan | EVP, Operations | Option Exercise | M | 50.44 | 6,000 | 302,640 | 0 | |
May 21 2013 | AMGN | AMGEN INC | Balachandran Madhavan | EVP, Operations | Sell | S | 103.28 | 6,000 | 619,681 | 34,851 | 40.9 K to 34.9 K (-14.69 %) |
May 21 2013 | AMGN | AMGEN INC | Balachandran Madhavan | EVP, Operations | Gift | G | 0.00 | 6,000 | 0 | 40,956 | 47 K to 41 K (-12.78 %) |
May 21 2013 | AMGN | AMGEN INC | Balachandran Madhavan | EVP, Operations | Gift | G | 0.00 | 6,000 | 0 | 40,851 | 34.9 K to 40.9 K (+17.22 %) |
May 21 2013 | AMGN | AMGEN INC | Balachandran Madhavan | EVP, Operations | Buy | M | 50.44 | 6,000 | 302,640 | 46,956 | 41 K to 47 K (+14.65 %) |
May 20 2013 | AMGN | AMGEN INC | HENDERSON REBECCA M | Director | Option Exercise | M | 54.69 | 5,000 | 273,450 | 0 | |
May 20 2013 | AMGN | AMGEN INC | HENDERSON REBECCA M | Director | Option Exercise | M | 58.43 | 2,000 | 116,860 | 3,000 | |
May 20 2013 | AMGN | AMGEN INC | HENDERSON REBECCA M | Director | Sell | S | 105.84 | 1,421 | 150,404 | 5,477 | 6.9 K to 5.5 K (-20.60 %) |
May 20 2013 | AMGN | AMGEN INC | HENDERSON REBECCA M | Director | Sell | S | 105.70 | 7,000 | 739,896 | 6,898 | 13.9 K to 6.9 K (-50.37 %) |
May 20 2013 | AMGN | AMGEN INC | HENDERSON REBECCA M | Director | Buy | M | 54.69 | 5,000 | 273,450 | 13,898 | 8.9 K to 13.9 K (+56.19 %) |
May 20 2013 | AMGN | AMGEN INC | HENDERSON REBECCA M | Director | Buy | M | 58.43 | 2,000 | 116,860 | 8,898 | 6.9 K to 8.9 K (+28.99 %) |
May 17 2013 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Option Exercise | M | 54.69 | 1,724 | 94,286 | 3,501 | |
May 17 2013 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Option Exercise | M | 58.43 | 920 | 53,756 | 920 | |
May 17 2013 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Option Exercise | M | 50.44 | 900 | 45,396 | 0 | |
May 17 2013 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Sell | S | 105.01 | 3,544 | 372,148 | 15,442 | 19 K to 15.4 K (-18.67 %) |
May 17 2013 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Buy | M | 54.69 | 1,724 | 94,286 | 18,986 | 17.3 K to 19 K (+9.99 %) |
May 17 2013 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Buy | M | 58.43 | 920 | 53,756 | 17,262 | 16.3 K to 17.3 K (+5.63 %) |
May 17 2013 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Buy | M | 50.44 | 900 | 45,396 | 16,342 | 15.4 K to 16.3 K (+5.83 %) |
May 16 2013 | AMGN | AMGEN INC | PELHAM JUDITH C | Director | Option Exercise | M | 71.64 | 5,000 | 358,200 | 0 | |
May 16 2013 | AMGN | AMGEN INC | PELHAM JUDITH C | Director | Option Exercise | M | 54.69 | 5,000 | 273,450 | 0 | |
May 16 2013 | AMGN | AMGEN INC | PELHAM JUDITH C | Director | Option Exercise | M | 58.43 | 5,000 | 292,150 | 0 | |
May 16 2013 | AMGN | AMGEN INC | PELHAM JUDITH C | Director | Option Exercise | M | 50.44 | 5,000 | 252,200 | 0 | |
May 16 2013 | AMGN | AMGEN INC | PELHAM JUDITH C | Director | Option Exercise | M | 42.13 | 5,000 | 210,650 | 0 | |
May 16 2013 | AMGN | AMGEN INC | PELHAM JUDITH C | Director | Sell | S | 108.25 | 25,000 | 2,706,165 | 23,149 | 48.1 K to 23.1 K (-51.92 %) |
May 16 2013 | AMGN | AMGEN INC | PELHAM JUDITH C | Director | Buy | M | 71.64 | 5,000 | 358,200 | 48,149 | 43.1 K to 48.1 K (+11.59 %) |
May 16 2013 | AMGN | AMGEN INC | PELHAM JUDITH C | Director | Buy | M | 54.69 | 5,000 | 273,450 | 43,149 | 38.1 K to 43.1 K (+13.11 %) |
May 16 2013 | AMGN | AMGEN INC | PELHAM JUDITH C | Director | Buy | M | 58.43 | 5,000 | 292,150 | 38,149 | 33.1 K to 38.1 K (+15.08 %) |
May 16 2013 | AMGN | AMGEN INC | PELHAM JUDITH C | Director | Buy | M | 50.44 | 5,000 | 252,200 | 33,149 | 28.1 K to 33.1 K (+17.76 %) |
May 16 2013 | AMGN | AMGEN INC | PELHAM JUDITH C | Director | Buy | M | 42.13 | 5,000 | 210,650 | 28,149 | 23.1 K to 28.1 K (+21.60 %) |
May 16 2013 | AMGN | AMGEN INC | BIONDI FRANK | Director | Option Exercise | M | 50.44 | 5,000 | 252,200 | 0 | |
May 16 2013 | AMGN | AMGEN INC | BIONDI FRANK | Director | Option Exercise | M | 62.55 | 5,000 | 312,750 | 0 | |
May 16 2013 | AMGN | AMGEN INC | BIONDI FRANK | Director | Sell | S | 108.43 | 10,000 | 1,084,318 | 29,780 | 39.8 K to 29.8 K (-25.14 %) |
May 16 2013 | AMGN | AMGEN INC | BIONDI FRANK | Director | Buy | M | 50.44 | 5,000 | 252,200 | 39,780 | 34.8 K to 39.8 K (+14.38 %) |
May 16 2013 | AMGN | AMGEN INC | BIONDI FRANK | Director | Buy | M | 62.55 | 5,000 | 312,750 | 34,780 | 29.8 K to 34.8 K (+16.79 %) |
May 06 2013 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Option Exercise | M | 50.44 | 8,000 | 403,520 | 0 | |
May 06 2013 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Sell | S | 106.32 | 8,000 | 850,590 | 64,180 | 72.2 K to 64.2 K (-11.08 %) |
May 06 2013 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Buy | M | 50.44 | 8,000 | 403,520 | 72,180 | 64.2 K to 72.2 K (+12.46 %) |
May 02 2013 | AMGN | AMGEN INC | de Carbonnel Francois | Director | Option Exercise | M | 54.74 | 10,000 | 547,400 | 0 | |
May 02 2013 | AMGN | AMGEN INC | de Carbonnel Francois | Director | Payment of Exercise | F | 106.67 | 6,593 | 703,275 | 15,337 | 21.9 K to 15.3 K (-30.06 %) |
May 02 2013 | AMGN | AMGEN INC | de Carbonnel Francois | Director | Buy | M | 54.74 | 10,000 | 547,400 | 21,930 | 11.9 K to 21.9 K (+83.82 %) |
Apr 30 2013 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Grant | A | 0.00 | 1,845 | 0 | 5,128 | 3.3 K to 5.1 K (+56.20 %) |
Apr 30 2013 | AMGN | AMGEN INC | SCHAEFFER LEONARD D | Director | Grant | A | 0.00 | 1,845 | 0 | 18,202 | 16.4 K to 18.2 K (+11.28 %) |
Apr 30 2013 | AMGN | AMGEN INC | REASON J PAUL | Director | Grant | A | 0.00 | 1,845 | 0 | 25,520 | 23.7 K to 25.5 K (+7.79 %) |
Apr 30 2013 | AMGN | AMGEN INC | PELHAM JUDITH C | Director | Grant | A | 0.00 | 1,845 | 0 | 23,149 | 21.3 K to 23.1 K (+8.66 %) |
Apr 30 2013 | AMGN | AMGEN INC | OMENN GILBERT S | Director | Grant | A | 0.00 | 1,845 | 0 | 178,669 | 176.8 K to 178.7 K (+1.04 %) |
Apr 30 2013 | AMGN | AMGEN INC | Jacks Tyler | Director | Grant | A | 0.00 | 1,845 | 0 | 1,890 | 45 to 1.9 K (+4,100.00 %) |
Apr 30 2013 | AMGN | AMGEN INC | HERRINGER FRANK C | Director | Grant | A | 0.00 | 1,845 | 0 | 18,171 | 16.3 K to 18.2 K (+11.30 %) |
Apr 30 2013 | AMGN | AMGEN INC | HENDERSON REBECCA M | Director | Grant | A | 0.00 | 1,845 | 0 | 6,898 | 5.1 K to 6.9 K (+36.51 %) |